Deciphera Pharmaceuticals, LLC
Waltham, MA
Works in Dermatology · GI & liver · Hematology · Immunology · Infectious disease · Metabolic & endocrine · Musculoskeletal · Oncology · Renal & urogenital · Respiratory · Women's health
Deciphera Pharmaceuticals, LLC is a clinical trial sponsor based in Waltham, MA. It has 10 active clinical trials with 1,192 planned participants, across 11 therapeutic areas. Since 2021 it has completed 6 trials and stopped 5 early. Its FDA record on file shows 1 inspection.
Trial track record · since 2021
FDA record
Recent FDA actions
Pipeline · 10 active trials
| Stage | Trial | Status |
|---|---|---|
On the market
2 approved drug applications with a product on the market.
Questions about Deciphera Pharmaceuticals, LLC
No warning letter naming Deciphera Pharmaceuticals, LLC is on file. FDA has published 1 inspection classification naming it.
FDA has posted 1 inspection classification naming Deciphera Pharmaceuticals, LLC. The latest inspection ended on 2026-06-03 and was classified NAI (no action indicated). FDA posts a classification after its review, often months after the inspection ended.
Deciphera Pharmaceuticals, LLC is lead sponsor of 10 active clinical trials on ClinicalTrials.gov, with 1,192 planned participants, in Dermatology, GI & liver, Hematology, Immunology and other areas. Since 2021 it has completed 6 trials and stopped 5 early.
Deciphera Pharmaceuticals, LLC is based in Waltham, MA. The address is the one on its FDA records or ClinicalTrials.gov registrations, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Deciphera Pharmaceuticals, LLC; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-16.
The FDA record counts inspection classifications, warning letters and recalls FDA has published that name this company. Compare it with the industry in the free CDMO FDA inspection lookup.
Approve Suite is not affiliated with Deciphera Pharmaceuticals, LLC. Informational only.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.